Percy Griffin, Ph.D., is director, Scientific Engagement for the Alzheimer’s Association, where he leads efforts to accelerate the organization’s scientific agenda through the creation and delivery of ongoing research education. He engages with more than 75 Association chapters across the country, informing staff and the public of scientific initiatives and the organization’s crucial role in advancing research to improve the lives of all those facing Alzheimer’s and other dementias.
Prior to joining the Association, Dr. Griffin held a number of roles that honed his expertise in research and scientific communication. Most recently, he was a strategic analyst for Purohit Navigation, where he conducted and analyzed research for pharmaceutical clients. He also served as a consultant for the Biotechnology and Life Sciences Advising Group and as a scientific editor and illustrator for InPrint, a publication editing service at Washington University in St. Louis.
As a researcher, Dr. Griffin has led independent translational projects in Parkinson’s and Alzheimer’s disease focused on protein degradation and neuroimmunology, in addition to research on the role of proteostasis in Parkinson's disease pathogenesis and organic chemistry synthesis. He is a co-author of several papers, including “Circadian clock protein Rev-erba regulates neuroinflammation,” published in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).
Dr. Griffin holds a doctorate in molecular cell biology from Washington University in St. Louis, a master’s degree in pharmacology from the University of Minnesota Medical School and a bachelor’s degree in biology and chemistry from Macalester College. During his graduate studies, Dr. Griffin participated in the optional Entrepreneurship for Biomedicine Research Training Program and earned a credential in Science Communication. He is a recipient of the Graduate Research Fellowship from the National Science Foundation and the Neuroscience Scholars Program Fellowship from the Society for Neuroscience.